Global Short Bowel Syndrome (SBS) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 92

Published Date: 02 Jan 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Short Bowel Syndrome (SBS) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrolyte disturbances, and malnutrition.

During 2017, the parental route segment accounted for the major shares and dominated the SBS market. Factors such as the rapid action mechanism of the drug and the prolonged action result contribute to the growth of this market segment in the coming years. In the parental route, the drug is administered intravenously, subcutaneously, intrathecally, or through intramuscular routes and is applied when the oral route of drug administration is ineffective.

The Global Info Research report includes an overview of the development of the Short Bowel Syndrome (SBS) industry chain, the market status of Hospitals (Oral Route, Parental Route), Clinics (Oral Route, Parental Route), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Short Bowel Syndrome (SBS).

Regionally, the report analyzes the Short Bowel Syndrome (SBS) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Short Bowel Syndrome (SBS) market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Short Bowel Syndrome (SBS) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Short Bowel Syndrome (SBS) industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Oral Route, Parental Route).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Short Bowel Syndrome (SBS) market.

Regional Analysis: The report involves examining the Short Bowel Syndrome (SBS) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Short Bowel Syndrome (SBS) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Short Bowel Syndrome (SBS):
Company Analysis: Report covers individual Short Bowel Syndrome (SBS) players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Short Bowel Syndrome (SBS) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Sale Channel (Hospitals, Clinics).

Technology Analysis: Report covers specific technologies relevant to Short Bowel Syndrome (SBS). It assesses the current state, advancements, and potential future developments in Short Bowel Syndrome (SBS) areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Short Bowel Syndrome (SBS) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Short Bowel Syndrome (SBS) market is split by Type and by Sale Channel. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Sale Channel in terms of value.

Market segment by Type
Oral Route
Parental Route

Market segment by Sale Channel
Hospitals
Clinics
Retail Pharmacies

Market segment by players, this report covers
Merck
Takeda
Emmaus Medical
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio Pharmaceuticals
Zealand Pharma

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Short Bowel Syndrome (SBS) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Short Bowel Syndrome (SBS), with revenue, gross margin and global market share of Short Bowel Syndrome (SBS) from 2019 to 2024.
Chapter 3, the Short Bowel Syndrome (SBS) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Short Bowel Syndrome (SBS) market forecast, by regions, type and sale channel, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Short Bowel Syndrome (SBS).
Chapter 13, to describe Short Bowel Syndrome (SBS) research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Short Bowel Syndrome (SBS)
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Short Bowel Syndrome (SBS) by Type
        1.3.1 Overview: Global Short Bowel Syndrome (SBS) Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Short Bowel Syndrome (SBS) Consumption Value Market Share by Type in 2023
        1.3.3 Oral Route
        1.3.4 Parental Route
    1.4 Global Short Bowel Syndrome (SBS) Market by Sale Channel
        1.4.1 Overview: Global Short Bowel Syndrome (SBS) Market Size by Sale Channel: 2019 Versus 2023 Versus 2030
        1.4.2 Hospitals
        1.4.3 Clinics
        1.4.4 Retail Pharmacies
    1.5 Global Short Bowel Syndrome (SBS) Market Size & Forecast
    1.6 Global Short Bowel Syndrome (SBS) Market Size and Forecast by Region
        1.6.1 Global Short Bowel Syndrome (SBS) Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Short Bowel Syndrome (SBS) Market Size by Region, (2019-2030)
        1.6.3 North America Short Bowel Syndrome (SBS) Market Size and Prospect (2019-2030)
        1.6.4 Europe Short Bowel Syndrome (SBS) Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Short Bowel Syndrome (SBS) Market Size and Prospect (2019-2030)
        1.6.6 South America Short Bowel Syndrome (SBS) Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Short Bowel Syndrome (SBS) Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Merck
        2.1.1 Merck Details
        2.1.2 Merck Major Business
        2.1.3 Merck Short Bowel Syndrome (SBS) Product and Solutions
        2.1.4 Merck Short Bowel Syndrome (SBS) Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Merck Recent Developments and Future Plans
    2.2 Takeda
        2.2.1 Takeda Details
        2.2.2 Takeda Major Business
        2.2.3 Takeda Short Bowel Syndrome (SBS) Product and Solutions
        2.2.4 Takeda Short Bowel Syndrome (SBS) Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Takeda Recent Developments and Future Plans
    2.3 Emmaus Medical
        2.3.1 Emmaus Medical Details
        2.3.2 Emmaus Medical Major Business
        2.3.3 Emmaus Medical Short Bowel Syndrome (SBS) Product and Solutions
        2.3.4 Emmaus Medical Short Bowel Syndrome (SBS) Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Emmaus Medical Recent Developments and Future Plans
    2.4 Ardelyx
        2.4.1 Ardelyx Details
        2.4.2 Ardelyx Major Business
        2.4.3 Ardelyx Short Bowel Syndrome (SBS) Product and Solutions
        2.4.4 Ardelyx Short Bowel Syndrome (SBS) Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Ardelyx Recent Developments and Future Plans
    2.5 Naia Pharmaceuticals
        2.5.1 Naia Pharmaceuticals Details
        2.5.2 Naia Pharmaceuticals Major Business
        2.5.3 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Product and Solutions
        2.5.4 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Naia Pharmaceuticals Recent Developments and Future Plans
    2.6 Nutrinia
        2.6.1 Nutrinia Details
        2.6.2 Nutrinia Major Business
        2.6.3 Nutrinia Short Bowel Syndrome (SBS) Product and Solutions
        2.6.4 Nutrinia Short Bowel Syndrome (SBS) Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Nutrinia Recent Developments and Future Plans
    2.7 OxThera
        2.7.1 OxThera Details
        2.7.2 OxThera Major Business
        2.7.3 OxThera Short Bowel Syndrome (SBS) Product and Solutions
        2.7.4 OxThera Short Bowel Syndrome (SBS) Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 OxThera Recent Developments and Future Plans
    2.8 Sancilio Pharmaceuticals
        2.8.1 Sancilio Pharmaceuticals Details
        2.8.2 Sancilio Pharmaceuticals Major Business
        2.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Product and Solutions
        2.8.4 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Sancilio Pharmaceuticals Recent Developments and Future Plans
    2.9 Zealand Pharma
        2.9.1 Zealand Pharma Details
        2.9.2 Zealand Pharma Major Business
        2.9.3 Zealand Pharma Short Bowel Syndrome (SBS) Product and Solutions
        2.9.4 Zealand Pharma Short Bowel Syndrome (SBS) Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Zealand Pharma Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Short Bowel Syndrome (SBS) Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Short Bowel Syndrome (SBS) by Company Revenue
        3.2.2 Top 3 Short Bowel Syndrome (SBS) Players Market Share in 2023
        3.2.3 Top 6 Short Bowel Syndrome (SBS) Players Market Share in 2023
    3.3 Short Bowel Syndrome (SBS) Market: Overall Company Footprint Analysis
        3.3.1 Short Bowel Syndrome (SBS) Market: Region Footprint
        3.3.2 Short Bowel Syndrome (SBS) Market: Company Product Type Footprint
        3.3.3 Short Bowel Syndrome (SBS) Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Short Bowel Syndrome (SBS) Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Short Bowel Syndrome (SBS) Market Forecast by Type (2025-2030)

5 Market Size Segment by Sale Channel
    5.1 Global Short Bowel Syndrome (SBS) Consumption Value Market Share by Sale Channel (2019-2024)
    5.2 Global Short Bowel Syndrome (SBS) Market Forecast by Sale Channel (2025-2030)

6 North America
    6.1 North America Short Bowel Syndrome (SBS) Consumption Value by Type (2019-2030)
    6.2 North America Short Bowel Syndrome (SBS) Consumption Value by Sale Channel (2019-2030)
    6.3 North America Short Bowel Syndrome (SBS) Market Size by Country
        6.3.1 North America Short Bowel Syndrome (SBS) Consumption Value by Country (2019-2030)
        6.3.2 United States Short Bowel Syndrome (SBS) Market Size and Forecast (2019-2030)
        6.3.3 Canada Short Bowel Syndrome (SBS) Market Size and Forecast (2019-2030)
        6.3.4 Mexico Short Bowel Syndrome (SBS) Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Short Bowel Syndrome (SBS) Consumption Value by Type (2019-2030)
    7.2 Europe Short Bowel Syndrome (SBS) Consumption Value by Sale Channel (2019-2030)
    7.3 Europe Short Bowel Syndrome (SBS) Market Size by Country
        7.3.1 Europe Short Bowel Syndrome (SBS) Consumption Value by Country (2019-2030)
        7.3.2 Germany Short Bowel Syndrome (SBS) Market Size and Forecast (2019-2030)
        7.3.3 France Short Bowel Syndrome (SBS) Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Short Bowel Syndrome (SBS) Market Size and Forecast (2019-2030)
        7.3.5 Russia Short Bowel Syndrome (SBS) Market Size and Forecast (2019-2030)
        7.3.6 Italy Short Bowel Syndrome (SBS) Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Short Bowel Syndrome (SBS) Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Short Bowel Syndrome (SBS) Consumption Value by Sale Channel (2019-2030)
    8.3 Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Region
        8.3.1 Asia-Pacific Short Bowel Syndrome (SBS) Consumption Value by Region (2019-2030)
        8.3.2 China Short Bowel Syndrome (SBS) Market Size and Forecast (2019-2030)
        8.3.3 Japan Short Bowel Syndrome (SBS) Market Size and Forecast (2019-2030)
        8.3.4 South Korea Short Bowel Syndrome (SBS) Market Size and Forecast (2019-2030)
        8.3.5 India Short Bowel Syndrome (SBS) Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Short Bowel Syndrome (SBS) Market Size and Forecast (2019-2030)
        8.3.7 Australia Short Bowel Syndrome (SBS) Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Short Bowel Syndrome (SBS) Consumption Value by Type (2019-2030)
    9.2 South America Short Bowel Syndrome (SBS) Consumption Value by Sale Channel (2019-2030)
    9.3 South America Short Bowel Syndrome (SBS) Market Size by Country
        9.3.1 South America Short Bowel Syndrome (SBS) Consumption Value by Country (2019-2030)
        9.3.2 Brazil Short Bowel Syndrome (SBS) Market Size and Forecast (2019-2030)
        9.3.3 Argentina Short Bowel Syndrome (SBS) Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Short Bowel Syndrome (SBS) Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Short Bowel Syndrome (SBS) Consumption Value by Sale Channel (2019-2030)
    10.3 Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Country
        10.3.1 Middle East & Africa Short Bowel Syndrome (SBS) Consumption Value by Country (2019-2030)
        10.3.2 Turkey Short Bowel Syndrome (SBS) Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Short Bowel Syndrome (SBS) Market Size and Forecast (2019-2030)
        10.3.4 UAE Short Bowel Syndrome (SBS) Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Short Bowel Syndrome (SBS) Market Drivers
    11.2 Short Bowel Syndrome (SBS) Market Restraints
    11.3 Short Bowel Syndrome (SBS) Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Short Bowel Syndrome (SBS) Industry Chain
    12.2 Short Bowel Syndrome (SBS) Upstream Analysis
    12.3 Short Bowel Syndrome (SBS) Midstream Analysis
    12.4 Short Bowel Syndrome (SBS) Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Short Bowel Syndrome (SBS) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Short Bowel Syndrome (SBS) Consumption Value by Sale Channel, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Short Bowel Syndrome (SBS) Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Short Bowel Syndrome (SBS) Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Merck Company Information, Head Office, and Major Competitors
    Table 6. Merck Major Business
    Table 7. Merck Short Bowel Syndrome (SBS) Product and Solutions
    Table 8. Merck Short Bowel Syndrome (SBS) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Merck Recent Developments and Future Plans
    Table 10. Takeda Company Information, Head Office, and Major Competitors
    Table 11. Takeda Major Business
    Table 12. Takeda Short Bowel Syndrome (SBS) Product and Solutions
    Table 13. Takeda Short Bowel Syndrome (SBS) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Takeda Recent Developments and Future Plans
    Table 15. Emmaus Medical Company Information, Head Office, and Major Competitors
    Table 16. Emmaus Medical Major Business
    Table 17. Emmaus Medical Short Bowel Syndrome (SBS) Product and Solutions
    Table 18. Emmaus Medical Short Bowel Syndrome (SBS) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Emmaus Medical Recent Developments and Future Plans
    Table 20. Ardelyx Company Information, Head Office, and Major Competitors
    Table 21. Ardelyx Major Business
    Table 22. Ardelyx Short Bowel Syndrome (SBS) Product and Solutions
    Table 23. Ardelyx Short Bowel Syndrome (SBS) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Ardelyx Recent Developments and Future Plans
    Table 25. Naia Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 26. Naia Pharmaceuticals Major Business
    Table 27. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Product and Solutions
    Table 28. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Naia Pharmaceuticals Recent Developments and Future Plans
    Table 30. Nutrinia Company Information, Head Office, and Major Competitors
    Table 31. Nutrinia Major Business
    Table 32. Nutrinia Short Bowel Syndrome (SBS) Product and Solutions
    Table 33. Nutrinia Short Bowel Syndrome (SBS) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Nutrinia Recent Developments and Future Plans
    Table 35. OxThera Company Information, Head Office, and Major Competitors
    Table 36. OxThera Major Business
    Table 37. OxThera Short Bowel Syndrome (SBS) Product and Solutions
    Table 38. OxThera Short Bowel Syndrome (SBS) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. OxThera Recent Developments and Future Plans
    Table 40. Sancilio Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 41. Sancilio Pharmaceuticals Major Business
    Table 42. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Product and Solutions
    Table 43. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Sancilio Pharmaceuticals Recent Developments and Future Plans
    Table 45. Zealand Pharma Company Information, Head Office, and Major Competitors
    Table 46. Zealand Pharma Major Business
    Table 47. Zealand Pharma Short Bowel Syndrome (SBS) Product and Solutions
    Table 48. Zealand Pharma Short Bowel Syndrome (SBS) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Zealand Pharma Recent Developments and Future Plans
    Table 50. Global Short Bowel Syndrome (SBS) Revenue (USD Million) by Players (2019-2024)
    Table 51. Global Short Bowel Syndrome (SBS) Revenue Share by Players (2019-2024)
    Table 52. Breakdown of Short Bowel Syndrome (SBS) by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 53. Market Position of Players in Short Bowel Syndrome (SBS), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 54. Head Office of Key Short Bowel Syndrome (SBS) Players
    Table 55. Short Bowel Syndrome (SBS) Market: Company Product Type Footprint
    Table 56. Short Bowel Syndrome (SBS) Market: Company Product Application Footprint
    Table 57. Short Bowel Syndrome (SBS) New Market Entrants and Barriers to Market Entry
    Table 58. Short Bowel Syndrome (SBS) Mergers, Acquisition, Agreements, and Collaborations
    Table 59. Global Short Bowel Syndrome (SBS) Consumption Value (USD Million) by Type (2019-2024)
    Table 60. Global Short Bowel Syndrome (SBS) Consumption Value Share by Type (2019-2024)
    Table 61. Global Short Bowel Syndrome (SBS) Consumption Value Forecast by Type (2025-2030)
    Table 62. Global Short Bowel Syndrome (SBS) Consumption Value by Sale Channel (2019-2024)
    Table 63. Global Short Bowel Syndrome (SBS) Consumption Value Forecast by Sale Channel (2025-2030)
    Table 64. North America Short Bowel Syndrome (SBS) Consumption Value by Type (2019-2024) & (USD Million)
    Table 65. North America Short Bowel Syndrome (SBS) Consumption Value by Type (2025-2030) & (USD Million)
    Table 66. North America Short Bowel Syndrome (SBS) Consumption Value by Sale Channel (2019-2024) & (USD Million)
    Table 67. North America Short Bowel Syndrome (SBS) Consumption Value by Sale Channel (2025-2030) & (USD Million)
    Table 68. North America Short Bowel Syndrome (SBS) Consumption Value by Country (2019-2024) & (USD Million)
    Table 69. North America Short Bowel Syndrome (SBS) Consumption Value by Country (2025-2030) & (USD Million)
    Table 70. Europe Short Bowel Syndrome (SBS) Consumption Value by Type (2019-2024) & (USD Million)
    Table 71. Europe Short Bowel Syndrome (SBS) Consumption Value by Type (2025-2030) & (USD Million)
    Table 72. Europe Short Bowel Syndrome (SBS) Consumption Value by Sale Channel (2019-2024) & (USD Million)
    Table 73. Europe Short Bowel Syndrome (SBS) Consumption Value by Sale Channel (2025-2030) & (USD Million)
    Table 74. Europe Short Bowel Syndrome (SBS) Consumption Value by Country (2019-2024) & (USD Million)
    Table 75. Europe Short Bowel Syndrome (SBS) Consumption Value by Country (2025-2030) & (USD Million)
    Table 76. Asia-Pacific Short Bowel Syndrome (SBS) Consumption Value by Type (2019-2024) & (USD Million)
    Table 77. Asia-Pacific Short Bowel Syndrome (SBS) Consumption Value by Type (2025-2030) & (USD Million)
    Table 78. Asia-Pacific Short Bowel Syndrome (SBS) Consumption Value by Sale Channel (2019-2024) & (USD Million)
    Table 79. Asia-Pacific Short Bowel Syndrome (SBS) Consumption Value by Sale Channel (2025-2030) & (USD Million)
    Table 80. Asia-Pacific Short Bowel Syndrome (SBS) Consumption Value by Region (2019-2024) & (USD Million)
    Table 81. Asia-Pacific Short Bowel Syndrome (SBS) Consumption Value by Region (2025-2030) & (USD Million)
    Table 82. South America Short Bowel Syndrome (SBS) Consumption Value by Type (2019-2024) & (USD Million)
    Table 83. South America Short Bowel Syndrome (SBS) Consumption Value by Type (2025-2030) & (USD Million)
    Table 84. South America Short Bowel Syndrome (SBS) Consumption Value by Sale Channel (2019-2024) & (USD Million)
    Table 85. South America Short Bowel Syndrome (SBS) Consumption Value by Sale Channel (2025-2030) & (USD Million)
    Table 86. South America Short Bowel Syndrome (SBS) Consumption Value by Country (2019-2024) & (USD Million)
    Table 87. South America Short Bowel Syndrome (SBS) Consumption Value by Country (2025-2030) & (USD Million)
    Table 88. Middle East & Africa Short Bowel Syndrome (SBS) Consumption Value by Type (2019-2024) & (USD Million)
    Table 89. Middle East & Africa Short Bowel Syndrome (SBS) Consumption Value by Type (2025-2030) & (USD Million)
    Table 90. Middle East & Africa Short Bowel Syndrome (SBS) Consumption Value by Sale Channel (2019-2024) & (USD Million)
    Table 91. Middle East & Africa Short Bowel Syndrome (SBS) Consumption Value by Sale Channel (2025-2030) & (USD Million)
    Table 92. Middle East & Africa Short Bowel Syndrome (SBS) Consumption Value by Country (2019-2024) & (USD Million)
    Table 93. Middle East & Africa Short Bowel Syndrome (SBS) Consumption Value by Country (2025-2030) & (USD Million)
    Table 94. Short Bowel Syndrome (SBS) Raw Material
    Table 95. Key Suppliers of Short Bowel Syndrome (SBS) Raw Materials
List of Figures
    Figure 1. Short Bowel Syndrome (SBS) Picture
    Figure 2. Global Short Bowel Syndrome (SBS) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Short Bowel Syndrome (SBS) Consumption Value Market Share by Type in 2023
    Figure 4. Oral Route
    Figure 5. Parental Route
    Figure 6. Global Short Bowel Syndrome (SBS) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 7. Short Bowel Syndrome (SBS) Consumption Value Market Share by Sale Channel in 2023
    Figure 8. Hospitals Picture
    Figure 9. Clinics Picture
    Figure 10. Retail Pharmacies Picture
    Figure 11. Global Short Bowel Syndrome (SBS) Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 12. Global Short Bowel Syndrome (SBS) Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 13. Global Market Short Bowel Syndrome (SBS) Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 14. Global Short Bowel Syndrome (SBS) Consumption Value Market Share by Region (2019-2030)
    Figure 15. Global Short Bowel Syndrome (SBS) Consumption Value Market Share by Region in 2023
    Figure 16. North America Short Bowel Syndrome (SBS) Consumption Value (2019-2030) & (USD Million)
    Figure 17. Europe Short Bowel Syndrome (SBS) Consumption Value (2019-2030) & (USD Million)
    Figure 18. Asia-Pacific Short Bowel Syndrome (SBS) Consumption Value (2019-2030) & (USD Million)
    Figure 19. South America Short Bowel Syndrome (SBS) Consumption Value (2019-2030) & (USD Million)
    Figure 20. Middle East and Africa Short Bowel Syndrome (SBS) Consumption Value (2019-2030) & (USD Million)
    Figure 21. Global Short Bowel Syndrome (SBS) Revenue Share by Players in 2023
    Figure 22. Short Bowel Syndrome (SBS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 23. Global Top 3 Players Short Bowel Syndrome (SBS) Market Share in 2023
    Figure 24. Global Top 6 Players Short Bowel Syndrome (SBS) Market Share in 2023
    Figure 25. Global Short Bowel Syndrome (SBS) Consumption Value Share by Type (2019-2024)
    Figure 26. Global Short Bowel Syndrome (SBS) Market Share Forecast by Type (2025-2030)
    Figure 27. Global Short Bowel Syndrome (SBS) Consumption Value Share by Sale Channel (2019-2024)
    Figure 28. Global Short Bowel Syndrome (SBS) Market Share Forecast by Sale Channel (2025-2030)
    Figure 29. North America Short Bowel Syndrome (SBS) Consumption Value Market Share by Type (2019-2030)
    Figure 30. North America Short Bowel Syndrome (SBS) Consumption Value Market Share by Sale Channel (2019-2030)
    Figure 31. North America Short Bowel Syndrome (SBS) Consumption Value Market Share by Country (2019-2030)
    Figure 32. United States Short Bowel Syndrome (SBS) Consumption Value (2019-2030) & (USD Million)
    Figure 33. Canada Short Bowel Syndrome (SBS) Consumption Value (2019-2030) & (USD Million)
    Figure 34. Mexico Short Bowel Syndrome (SBS) Consumption Value (2019-2030) & (USD Million)
    Figure 35. Europe Short Bowel Syndrome (SBS) Consumption Value Market Share by Type (2019-2030)
    Figure 36. Europe Short Bowel Syndrome (SBS) Consumption Value Market Share by Sale Channel (2019-2030)
    Figure 37. Europe Short Bowel Syndrome (SBS) Consumption Value Market Share by Country (2019-2030)
    Figure 38. Germany Short Bowel Syndrome (SBS) Consumption Value (2019-2030) & (USD Million)
    Figure 39. France Short Bowel Syndrome (SBS) Consumption Value (2019-2030) & (USD Million)
    Figure 40. United Kingdom Short Bowel Syndrome (SBS) Consumption Value (2019-2030) & (USD Million)
    Figure 41. Russia Short Bowel Syndrome (SBS) Consumption Value (2019-2030) & (USD Million)
    Figure 42. Italy Short Bowel Syndrome (SBS) Consumption Value (2019-2030) & (USD Million)
    Figure 43. Asia-Pacific Short Bowel Syndrome (SBS) Consumption Value Market Share by Type (2019-2030)
    Figure 44. Asia-Pacific Short Bowel Syndrome (SBS) Consumption Value Market Share by Sale Channel (2019-2030)
    Figure 45. Asia-Pacific Short Bowel Syndrome (SBS) Consumption Value Market Share by Region (2019-2030)
    Figure 46. China Short Bowel Syndrome (SBS) Consumption Value (2019-2030) & (USD Million)
    Figure 47. Japan Short Bowel Syndrome (SBS) Consumption Value (2019-2030) & (USD Million)
    Figure 48. South Korea Short Bowel Syndrome (SBS) Consumption Value (2019-2030) & (USD Million)
    Figure 49. India Short Bowel Syndrome (SBS) Consumption Value (2019-2030) & (USD Million)
    Figure 50. Southeast Asia Short Bowel Syndrome (SBS) Consumption Value (2019-2030) & (USD Million)
    Figure 51. Australia Short Bowel Syndrome (SBS) Consumption Value (2019-2030) & (USD Million)
    Figure 52. South America Short Bowel Syndrome (SBS) Consumption Value Market Share by Type (2019-2030)
    Figure 53. South America Short Bowel Syndrome (SBS) Consumption Value Market Share by Sale Channel (2019-2030)
    Figure 54. South America Short Bowel Syndrome (SBS) Consumption Value Market Share by Country (2019-2030)
    Figure 55. Brazil Short Bowel Syndrome (SBS) Consumption Value (2019-2030) & (USD Million)
    Figure 56. Argentina Short Bowel Syndrome (SBS) Consumption Value (2019-2030) & (USD Million)
    Figure 57. Middle East and Africa Short Bowel Syndrome (SBS) Consumption Value Market Share by Type (2019-2030)
    Figure 58. Middle East and Africa Short Bowel Syndrome (SBS) Consumption Value Market Share by Sale Channel (2019-2030)
    Figure 59. Middle East and Africa Short Bowel Syndrome (SBS) Consumption Value Market Share by Country (2019-2030)
    Figure 60. Turkey Short Bowel Syndrome (SBS) Consumption Value (2019-2030) & (USD Million)
    Figure 61. Saudi Arabia Short Bowel Syndrome (SBS) Consumption Value (2019-2030) & (USD Million)
    Figure 62. UAE Short Bowel Syndrome (SBS) Consumption Value (2019-2030) & (USD Million)
    Figure 63. Short Bowel Syndrome (SBS) Market Drivers
    Figure 64. Short Bowel Syndrome (SBS) Market Restraints
    Figure 65. Short Bowel Syndrome (SBS) Market Trends
    Figure 66. Porters Five Forces Analysis
    Figure 67. Manufacturing Cost Structure Analysis of Short Bowel Syndrome (SBS) in 2023
    Figure 68. Manufacturing Process Analysis of Short Bowel Syndrome (SBS)
    Figure 69. Short Bowel Syndrome (SBS) Industrial Chain
    Figure 70. Methodology
    Figure 71. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Merck
Takeda
Emmaus Medical
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio Pharmaceuticals
Zealand Pharma

Related Reports

Global Short Bowel Syndrome (SBS) Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Short Bowel Syndrome (SBS) Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 04 Jan 2023

date Medical Care

Product Tags

Short Bowel Syndrome (SBS)

Short Bowel Syndrome (SBS) Drugs

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>